Predicting response:
serotonin reuptake inhibition
by
Mendlewicz J
Free University of Brussels,
Department of Psychiatry, Belgium.
Int Clin Psychopharmacol 1999 May; 14 Suppl 1:S17-20

ABSTRACT

The introduction of selective serotonin reuptake inhibitors (SSRIs) has helped clarify our understanding of the actions of serotonin in depression. The serotonergic network of the central and peripheral nervous systems comprises many different pathways and at least 14 distinct serotonin receptors. By using our knowledge of neuroanatomy and the pharmacology of SSRIs, it is possible to predict many of the therapeutic and non-therapeutic effects of modulating serotonin levels. The efficacy of SSRIs in mild to moderate depression is well established but their efficacy in severe depression varies, compared with tricyclic antidepressants. The SSRIs also have predictable effects in a range of other affective disorders including obsessive-compulsive disorder, anxiety and bulimia, the efficacy varying between the different SSRIs. The adverse event profile is different from that of the tricyclic antidepressants and again is predictable through an understanding of the different serotonergic pathways.

OCD
SSRIs
Options
Reboxetine
SSRIs/SNRIs
SSRIs: review
NARIs and SSRIs
SSRIs v venlafaxine
SSRIs and smokers' hearts
Treatment-resistant depression
Noradrenaline reuptake inhibition
SSRIs compared with tricyclic antidepressants
Are SSRI antidepressants little better than placebos?

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family